When you’re struggling with breakouts, your skin care routine becomes a true science and the last step is finding a sunscreen for acne-prone skin that will keep it both protected and happy.

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

than with trastuzumab (15.7%), primarily due to thrombocytopenia and elevated transaminases. However, no new safety signals emerged with long-term follow-up. Post-treatment adverse cardiac events and ...

Alteogen will receive an upfront payment of $20 million, with another $280 million on offer from Daiichi Sankyo if the new formulation of Enhertu (trastuzumab ... layer of skin, making it possible ...